Junyuan Jerry Wang sold $163k of NUVB
CEO, ANHEART THERAPEUTICS LTD. at Nuvation Bio Inc.. 56,361 shares at an average of $2.89, traded Nov 11, 2024, filed Nov 13, 2024.
Score components
- +25RoleCEO
- +11Trade size$163k at market
- 0Share of holdings soldSold 1.4% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -11.5%, 3m -22.7%, 6m -26.4%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001415889-24-026701, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 11, 2024 | SOpen-market sale Class A Common Stock | -56,361 | $2.89 | $163k | 3,866,228 | Nov 13, 2024 |
Related signals
Other insiders at Nuvation Bio Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 60Notable | Nuvation Bio Inc. | Dongfang Liu CHIEF MEDICAL OFFICER | $1.2M 150,000 shares | -89% | |
| 46Moderate | Nuvation Bio Inc. | Dongfang Liu CHIEF MEDICAL OFFICER | $155k 20,000 shares | -71% | |
| 60Notable | Nuvation Bio Inc. | Gary Hattersley CHIEF SCIENTIFIC OFFICER | $2.7M 369,051 shares | -534% | |
| 46Moderate | Nuvation Bio Inc. | Dongfang Liu CHIEF MEDICAL OFFICER | $140k 20,000 shares | -53% | |
| 60Notable | Nuvation Bio Inc. | David C. Hanley CHIEF TECHNICAL OPERATIONS | $1.4M 200,000 shares | -89% | |
| 46Moderate | Nuvation Bio Inc. | Dongfang Liu CHIEF MEDICAL OFFICER | $148k 30,000 shares | -100% | |
| 18Weak | Nuvation Bio Inc. | Gary Hattersley CHIEF SCIENTIFIC OFFICER | $502k 100,000 shares | -100% | |
| 72Notable | Nuvation Bio Inc. | David Hung PRESIDENT AND CEO | $894k 500,000 shares | +1% | |
| 58Moderate | Nuvation Bio Inc. | Stacy Markel CHIEF PEOPLE OFFICER | $17k 10,000 shares | +51% | |
| 55Moderate | Nuvation Bio Inc. | Kerry Wentworth CHIEF REGULATORY OFFICER | $90k 50,000 shares | - |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.